Valerie Jansen
Fortune : - $ au 31/08/2026
Fortune : - $ au 31/08/2026
Valerie Malyvanh Jansen is currently an Independent Director at OnKure Therapeutics, Inc. since 2024.
Former roles include Chief Medical Officer at Elevation Oncology, Inc. from 2021 to 2025 and Executive Medical Director at Mersana Therapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Maryville College, and doctorate degrees from The University of Tennessee Health Science Center and Pritzker School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 07/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|
| Sociétés | Poste | Fin |
|---|---|---|
| ELEN ONCO | Directeur Technique/Scientifique/R&D | 31/03/2025 |
| MERSANA THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/04/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Maryville College
Maryville College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tennessee Health Science Center
The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elevation Oncology, Inc.
Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national